Todd T. Moore

3.5k total citations · 2 hit papers
17 papers, 2.8k citations indexed

About

Todd T. Moore is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Todd T. Moore has authored 17 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Todd T. Moore's work include Pancreatic and Hepatic Oncology Research (7 papers), T-cell and B-cell Immunology (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Todd T. Moore is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), T-cell and B-cell Immunology (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Todd T. Moore collaborates with scholars based in United States, Switzerland and Germany. Todd T. Moore's co-authors include Udaya Liyanage, David C. Linehan, Peter S. Goedegebuure, Timothy J. Eberlein, Rosa F. Hwang, Craig D. Logsdon, Steven M. Strasberg, Yoshiyuki Tanaka, Gerard M. Doherty and Virginia M. Herrmann and has published in prestigious journals such as The Journal of Immunology, Cancer and Cancer Research.

In The Last Decade

Todd T. Moore

17 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma

2002 1.2k citations Udaya Liyanage, Todd T. Moore et al. The Journal of Immunology profile →
Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression

2008 897 citations Rosa F. Hwang, Todd T. Moore et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd T. Moore United States	12	1.8k	1.4k	686	373	319	17	2.8k
Yibei Zhu China	27	1.8k 1.0×	2.1k 1.4×	538 0.8×	225 0.6×	415 1.3×	55	3.1k
Kazuaki Chikamatsu Japan	29	1.7k 0.9×	1.1k 0.8×	865 1.3×	500 1.3×	405 1.3×	152	3.0k
Ursina Teitelbaum United States	19	1.9k 1.1×	1.2k 0.8×	596 0.9×	452 1.2×	275 0.9×	54	2.7k
Serena S. Kwek United States	20	1.5k 0.8×	1.2k 0.8×	701 1.0×	236 0.6×	165 0.5×	27	2.3k
Tomohide Tsukahara Japan	29	1.2k 0.7×	1.0k 0.7×	982 1.4×	315 0.8×	152 0.5×	118	2.4k
Sydney Gordon United States	8	1.4k 0.8×	1.7k 1.2×	740 1.1×	210 0.6×	185 0.6×	10	2.8k
Jake S. O’Donnell Australia	12	2.1k 1.1×	1.4k 1.0×	885 1.3×	353 0.9×	294 0.9×	17	3.1k
Yu Kato Japan	15	1.8k 1.0×	1.5k 1.0×	472 0.7×	215 0.6×	159 0.5×	30	2.7k
Colm R. Duffy United States	4	1.6k 0.9×	1.1k 0.8×	514 0.7×	209 0.6×	127 0.4×	11	2.3k
Kei Hiraoka Japan	20	1.2k 0.7×	887 0.6×	605 0.9×	214 0.6×	291 0.9×	41	2.1k

Countries citing papers authored by Todd T. Moore

Since Specialization

Citations

This map shows the geographic impact of Todd T. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd T. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd T. Moore more than expected).

Fields of papers citing papers by Todd T. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd T. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd T. Moore. The network helps show where Todd T. Moore may publish in the future.

Co-authorship network of co-authors of Todd T. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Todd T. Moore. A scholar is included among the top collaborators of Todd T. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd T. Moore. Todd T. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Cleaver, Ondine, et al.. (2023). A WNT4- and DKK3-driven canonical to noncanonical Wnt signaling switch controls multiciliogenesis. Journal of Cell Science. 136(16). 4 indexed citations

Zhou, Liran, Todd T. Moore, Mason Lu, et al.. (2018). Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Science Translational Medicine. 10(464). 31 indexed citations

Świdnicka‐Siergiejko, Agnieszka, Myrriah Chavez-Tomar, Gregory B. Lesinski, et al.. (2017). Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment. Cancer Research. 77(10). 2647–2660. 114 indexed citations

Hwang, Rosa F., Todd T. Moore, Maureen M. Hattersley, et al.. (2012). Inhibition of the Hedgehog Pathway Targets the Tumor-Associated Stroma in Pancreatic Cancer. Molecular Cancer Research. 10(9). 1147–1157. 82 indexed citations

Small, William, John S James, Todd T. Moore, et al.. (2009). A Phase II Randomized Trial with Captopril in Patients Who Have Received Radiation Therapy +/- Chemotherapy for Stage II–IIIB Non–small Cell Lung Cancer and Stage I Central Non–small Cell Lung Cancer, or Limited-stage Small–cell Lung Cancer: RTOG 0123. International Journal of Radiation Oncology*Biology*Physics. 75(3). S461–S462. 4 indexed citations

Rivera, Armando, et al.. (2008). TUMOR-ASSOCIATED PANCREATIC STELLATE CELLS STIMULATE ANGIOGENESIS IN VITRO AND IN AN ORTHOTOPIC MODEL OF PANCREATIC CANCER. Pancreas. 37(4). 492–492. 1 indexed citations

Hwang, Rosa F., Todd T. Moore, Thiruvengadam Arumugam, et al.. (2008). Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression. Cancer Research. 68(3). 918–926. 897 indexed citations breakdown →

Amos, Keith D., Todd T. Moore, Thiruvengadam Arumugam, Craig D. Logsdon, & Rosa F. Hwang. (2006). Pancreatic stellate cells promote malignant potential in pancreatic cancer. Cancer Research. 66. 396–396. 2 indexed citations

Liyanage, Udaya, Peter S. Goedegebuure, Todd T. Moore, et al.. (2006). Increased Prevalence of Regulatory T Cells (Treg) is Induced by Pancreas Adenocarcinoma. Journal of Immunotherapy. 29(4). 416–424. 90 indexed citations

10.

Viehl, Carsten T., Todd T. Moore, Udaya Liyanage, et al.. (2006). Depletion of CD4+CD25+ Regulatory T Cells Promotes a Tumor-Specific Immune Response in Pancreas Cancer–Bearing Mice. Annals of Surgical Oncology. 13(9). 1252–1258. 121 indexed citations

11.

Viehl, Carsten T., Udaya Liyanage, Todd T. Moore, et al.. (2004). Depletion of regulatory T cells promotes a tumor-specific immune response. Annals of Surgical Oncology. 11(S2). S69–S69. 1 indexed citations

12.

Liyanage, Udaya, Todd T. Moore, Hong‐Gu Joo, et al.. (2002). Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma. The Journal of Immunology. 169(5). 2756–2761. 1194 indexed citations breakdown →

13.

Safran, Howard, Todd T. Moore, David A. Iannitti, et al.. (2001). Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. International Journal of Radiation Oncology*Biology*Physics. 49(5). 1275–1279. 54 indexed citations

14.

Safran, Howard, Margaret M. Steinhoff, Shamlal Mangray, et al.. (2001). Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma. American Journal of Clinical Oncology. 24(5). 496–499. 134 indexed citations

15.

Safran, Howard, Henning A. Gaissert, Paul Akerman, et al.. (2001). Paclitaxel, Cisplatin, and Concurrent Radiation for Esophageal Cancer. Cancer Investigation. 19(1). 1–7. 50 indexed citations

16.

Safran, Howard, Harry Wanebo, Paul J. Hesketh, et al.. (2000). Paclitaxel and concurrent radiation for gastric cancer. International Journal of Radiation Oncology*Biology*Physics. 46(4). 889–894. 26 indexed citations

17.

King, Thomas C., Wallace Akerley, Alice C. Fan, et al.. (2000). p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma. Cancer. 89(4). 769–773. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact